What Are the New Treatments for Plantar Fasciitis?

The treatment landscape for plantar fasciitis has expanded well beyond cortisone shots and stretching routines. Platelet-rich plasma injections, shockwave therapy, botulinum toxin, amniotic tissue products, ultrasonic tissue removal, and even 3D-printed orthotics are all either in clinical use or moving rapidly through trials. What makes these newer approaches especially relevant is a shift in how the condition itself is understood: the problem is less about inflammation than it is about tissue degeneration, which means treatments that promote actual repair, rather than simply suppressing symptoms, have a stronger rationale than they did a decade ago.

The Condition Itself Is Being Rethought

For years, “plantar fasciitis” implied an inflammatory process, but research into the tissue changes has complicated that picture. When pathologists examine affected fascia, what they typically find is degeneration of collagen fibers and micro-tears rather than the swarms of immune cells that define true inflammation. That pattern resembles tendinosis more than tendinitis, which is why many specialists now prefer the term “plantar fasciopathy.”¹ The distinction matters because it shifts the treatment rationale. Anti-inflammatory drugs and corticosteroid injections can mask pain, but they do not rebuild degenerated collagen. Treatments that stimulate new blood vessel growth or recruit cells capable of laying down fresh tissue have a stronger theoretical basis for this kind of injury.

The condition also tends to resolve on its own. Over 80% of people with plantar fasciitis experience complete resolution within 12 months, a fact that complicates research into every treatment option. When a placebo group improves substantially because of the disease’s natural course, it raises the bar for any new therapy to prove its worth.² Keep that context in mind as we go through the newer options.

Platelet-Rich Plasma Injections

Platelet-rich plasma, or PRP, is drawn from your own blood, concentrated to pack in growth factors, and injected directly into the damaged fascia. The idea is to accelerate the tissue repair that the body is already (slowly) attempting. Of all the newer injection options, PRP has the most clinical data behind it for plantar fasciitis.

A randomized trial comparing PRP to corticosteroid and placebo injections followed patients for 18 months. All three groups improved, but the trajectories diverged. Corticosteroid injections delivered faster pain relief in the first weeks, while PRP overtook them in the longer term. By 18 months, PRP patients had significantly better pain scores and lower rates of needing additional injections or surgery.³ A separate comparative study found that while PRP and corticosteroid injections performed similarly at three and six months, PRP’s effect held steady through 12 months, whereas the steroid group’s scores drifted back toward pain.⁴

A systematic review and meta-analysis pooling multiple trials reinforced this pattern. PRP injections produced significantly better pain scores than corticosteroid injections at three months and six months, with no significant difference at one month (when steroids still held an edge) or at 12 months (where the gap narrowed but trended in PRP’s favor).⁵ The practical takeaway is that PRP tends to be a slower start with a more durable finish. If you need pain relief next week, a corticosteroid injection still works faster. But if you want lasting improvement and fewer repeat procedures, PRP has a stronger case.

Amniotic Tissue Injections

A step further into regenerative medicine involves injections made from processed human amniotic membrane or amniotic fluid, the tissue that surrounds a developing fetus. These products contain a cocktail of growth factors, anti-inflammatory molecules, and structural proteins thought to support tissue repair. They are typically derived from donated placental tissue after planned cesarean deliveries.

Small studies have shown encouraging results. In patients whose heel pain had not responded to standard treatments, injections of granulized amniotic membrane and amniotic fluid led to significant pain reduction.⁶ A randomized controlled trial of micronized dehydrated human amnion/chorion membrane injection found statistically significant and clinically meaningful improvements in both pain and function compared to placebo.⁷ A separate pilot study using cryopreserved amniotic membrane found it was safe and performed comparably to corticosteroid injection, though the researchers emphasized that larger trials are needed.⁸

The evidence here is promising but thin. Most studies involve small numbers of patients, and the products vary between manufacturers. These injections are also not typically covered by insurance, so cost can be a significant factor. They are worth knowing about, especially for cases that have resisted other treatments, but they are not yet on the same evidence footing as PRP.

Botulinum Toxin for Heel Pain

Botulinum toxin, the same protein used in cosmetic wrinkle treatments, has been studied as a surprisingly effective option for stubborn plantar fasciitis. A randomized placebo-controlled trial injecting botulinum toxin into the foot found that at six months, patients’ function scores roughly doubled and pain scores were cut in half. Those improvements held at 12 months, and none of the patients who received the toxin went on to need surgery, compared to 12% of the placebo group.⁹

The mechanism is more complex than simple muscle relaxation. Botulinum toxin blocks the release of pain-signaling molecules at nerve endings, an analgesic effect that goes beyond its well-known paralytic action. It also appears to reduce peripheral nerve sensitization, which in turn dials down the amplified pain signaling that develops in chronic conditions. When injected into the small muscles of the foot, the resulting relaxation reduces mechanical tension on the plantar fascia itself. It may also relieve compression on small nerve branches that get pinched between tense structures.¹⁰ One intriguing observation is that pain relief can last up to 12 months from a single injection, far longer than the toxin’s paralytic effect, which wears off in a few months. The reduction in central sensitization may explain why the benefit outlasts the direct pharmacological action.

Shockwave Therapy

Extracorporeal shockwave therapy, commonly called ESWT, uses focused acoustic pulses delivered through the skin to the damaged fascia. It has been around for over a decade but has become more refined and more widely available. The working theory is that the shockwaves create controlled micro-damage in tissue that has poor blood supply, triggering the body to send growth factors and stem cells to kick-start repair and blood vessel formation.¹¹ Sessions are done in an office setting, usually over the course of several weeks, and the procedure causes some discomfort but does not require anesthesia or downtime.

ESWT is now one of the more widely endorsed non-surgical treatments for plantar fasciitis that has not responded to conservative care. Its evidence base is broader than many of the injection therapies, and it avoids the systemic concerns of repeated corticosteroid injections. It works especially well as a middle step between failed conservative measures and more invasive procedures.

High-Intensity Laser Therapy

High-intensity laser therapy, or HILT, aims to deliver energy deep into tissue to reduce pain and promote healing. One randomized trial comparing HILT to shockwave therapy found that patients in the laser group reported less pain, better physical function, and improved mental health scores at three months, suggesting HILT may outperform ESWT in certain measures.¹²

However, a separate randomized, sham-controlled trial painted a very different picture. When HILT was combined with standard stretching exercises and compared against a sham laser plus the same stretches, the real laser offered no additional benefit in pain reduction, fascia thickness, or functional scores.¹³ The discrepancy between these studies is a useful reminder that a therapy can look good when compared to another active treatment (where both groups might improve from natural healing) but fail to beat a sham control. HILT remains a question mark, and anyone considering it should be skeptical of clinics that market it as a proven breakthrough.

Ultrasonic Debridement and Radiofrequency

For patients whose pain persists after months of conservative treatment, two minimally invasive, office-based procedures have emerged as alternatives to traditional surgery. Percutaneous ultrasonic tenotomy, or PUT, uses ultrasound energy delivered through a small needle-like probe to break down and remove damaged tissue within the fascia. A retrospective review found that pain scores dropped substantially after PUT, from an average range of roughly 6 to 9 before the procedure down to about 1 to 3 afterward, with a large statistical effect size confirming the improvement was clinically meaningful, not just numerically detectable.¹⁴ A systematic review across multiple types of tendon problems confirmed that PUT consistently reduced pain and improved function for both chronic tendinopathy and plantar fasciitis.¹⁵

Radiofrequency microtenotomy, marketed under the brand name Topaz, works on a similar principle. A probe delivers controlled radiofrequency energy through tiny skin punctures to stimulate a healing response in the degenerated tissue. A meta-analysis of available studies found an average pain reduction of nearly 6 points on a 10-point scale, a low complication rate of around 3%, patient satisfaction of about 90%, and rapid recovery.¹⁶ Both PUT and radiofrequency sit in a useful niche between injections and full surgical release, offering tissue-level intervention without the recovery time of open surgery.

High-Load Strength Training

Not every promising treatment involves a needle or a device. A randomized controlled trial tested a simple progressive heel-raise exercise performed every other day, using a towel rolled under the toes to maximize load on the plantar fascia. At three months, the strength-training group scored 29 points better on a foot function index than a group doing the standard recommended stretching protocol.¹⁷ The logic fits the tissue-degeneration model well: progressive loading is already a cornerstone of tendinopathy rehabilitation, and the plantar fascia responds to similar stimuli. For anyone in the early stages of plantar fasciitis, this is the kind of treatment that costs nothing and can be started immediately.

3D-Printed Custom Orthotics

Foot orthotics have long been part of plantar fasciitis management, but the technology for making them is changing. 3D-printed insoles, designed from digital scans of your foot, are now being tested against traditional custom-made and prefabricated options. In a study of 60 patients with bilateral plantar fasciitis, 3D-printed insoles redistributed pressure more effectively than prefabricated ones, shifting load away from the mid-heel and lateral foot. They also reduced pain scores by an average of about 4 points, compared to roughly 3.5 points for the prefabricated version.¹⁸

Biomechanical testing in flat-footed patients with plantar fasciitis found that 3D-printed orthotics were more effective at reducing arch collapse during walking than traditionally made ones, while both types equally improved ankle mechanics compared to no orthotic at all.¹⁹ A systematic review of 3D-printed orthoses across multiple foot conditions confirmed that these devices effectively redistribute pressure and improve comfort.²⁰ The practical advantage is turnaround time and precision: a digital scan can be taken in minutes, and the orthotic can be iteratively adjusted without starting from scratch. Whether 3D-printed orthotics justify their current premium over a good prefabricated insert depends on the severity of your symptoms and how much structural correction your foot needs.

Corticosteroid Risks Worth Knowing

Corticosteroid injections remain widely used, but the newer options above have gained traction partly because of growing awareness of steroid limitations. Beyond the pattern of short-lived relief, there is a small but real risk of plantar fascia rupture. A Cochrane review that pooled adverse-event data from 21 trials found two fascia ruptures and three injection-site infections among about 700 patients who received steroid injections.²¹ Those are low numbers in absolute terms, but fascia rupture can be a debilitating complication that changes foot mechanics permanently. Physicians are increasingly weighing that risk against the fact that corticosteroids do not address the underlying degeneration and tend to lose effectiveness over several months.²² This is one of the reasons PRP and other biologic injections have gained ground: they aim to repair tissue rather than simply suppress pain, without the structural risks of repeated steroids.

Advances in Surgical Technique

When all conservative and minimally invasive options fail, surgical release of the plantar fascia is still an option, but the procedure itself is evolving. A recent study compared traditional endoscopic plantar fascia release to a modified version guided by real-time ultrasound imaging. Both groups saw significant improvement in pain and function at one, six, and 12 months, with no meaningful difference in outcomes. The ultrasound-guided group, however, had significantly fewer postoperative complications and higher patient satisfaction.²³ The advantage is precision: surgeons can see exactly where they are cutting in real time, reducing the chance of releasing too much tissue or damaging nearby structures. This is a safety improvement rather than a cure-rate improvement, but for someone facing surgery, fewer complications is the more valuable gain.

Better Diagnostic Imaging

Diagnosing plantar fasciitis has traditionally relied on physical examination and standard ultrasound, which measures how thick the fascia is. A thickness greater than 4 millimeters is the classic diagnostic cutoff, but it misses a meaningful number of cases. Shear wave elastography, a newer ultrasound technique that measures tissue stiffness rather than just thickness, is filling that gap. In a prospective study, standard ultrasound thickness measurements caught only 21 of 30 confirmed cases, while adding elastography identified an additional eight that would have been missed on conventional imaging alone.²⁴ The technique predicted plantar fasciitis with 97% sensitivity and 100% specificity, making it a potentially powerful tool for catching early or atypical cases. Researchers are also using elastography to compare fascia stiffness between healthy individuals and patients with plantar fasciitis, which could eventually help track treatment response over time.²⁵

Weight, Footwear, and Physical Therapy Economics

No treatment works in isolation, and body weight is one of the strongest modifiable risk factors for plantar fasciitis. Higher BMI decreases the stiffness and increases the thickness of the plantar fascia, essentially weakening it under greater load.²⁶ A study of patients with plantar heel spurs found that obesity roughly tripled the odds of developing painful symptoms, making it an independent risk factor comparable to the size of the spur itself.²⁷ For anyone dealing with recurrent plantar fasciitis, weight management deserves to be treated as a first-line intervention alongside everything else.

Footwear choices also matter, though the evidence here is more nuanced than shoe companies sometimes suggest. Rocker-soled shoes with a stiff insole do reduce toe extension angles and certain ankle forces during walking, but a biomechanical study found they did not significantly reduce the actual strain on the plantar fascia. The effects on different phases of the walking cycle essentially cancel each other out.²⁸ Rocker shoes might still feel more comfortable because they change how forces travel through the foot, but the claim that they directly unload the plantar fascia is not well supported.

On the economics side, a recent trial found that adding physical therapy to standard podiatric care for plantar heel pain reduced total societal costs by roughly $2,700 per patient while also improving quality of life. The probability that this combination was cost-effective reached 98% at standard willingness-to-pay thresholds.²⁹ In a field full of expensive injections and high-tech devices, that result is a useful anchor: structured physical therapy remains one of the most cost-effective things you can do.

Extracellular Vesicles and the Research Frontier

The farthest edge of plantar fasciitis treatment involves cell-free biologics, specifically tiny particles called extracellular vesicles derived from mesenchymal stem cells. These vesicles carry signaling molecules that can nudge the immune system toward a repair-oriented state, suppress destructive enzymes that break down connective tissue, and promote new blood vessel formation. Preclinical studies in tendon and ligament models suggest they could improve healing, and researchers have begun exploring them specifically for plantar fasciopathy.³⁰ This is still firmly in the experimental stage, with no human clinical trials for plantar fasciitis specifically. But the approach represents the logical next step of the regenerative philosophy that already drives PRP and amniotic tissue treatments: rather than suppressing symptoms, you deliver the body’s own repair signals directly to the site of damage. Whether extracellular vesicles eventually prove more effective than existing biologics, or simply more expensive, remains to be seen.